imatinib mesylate has been researched along with Cancer of Muscle in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Sun, W; Wang, H; Ye, S; Zhu, G | 1 |
| Benchakroun, N; Benider, A; Bouchbika, Z; Dao, A; Jabir, H; Jouhadi, H; Sahraoui, S; Taleb, A; Tawfiq, N | 1 |
| Abboud, HE; Grayson, MH; Infante, AJ; Keller, C; Legallo, RD; McCleish, AT; Michalek, JE; Nishijo, K; Qualman, SJ; Rubin, BP; Taniguchi, E | 1 |
3 other study(ies) available for imatinib mesylate and Cancer of Muscle
| Article | Year |
|---|---|
Skeletal muscle metastasis from a gastrointestinal stromal tumor: A case report.
Topics: Drug Resistance, Neoplasm; Exome Sequencing; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Sunitinib; Thigh | 2021 |
Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report.
Topics: Adult; Antineoplastic Agents; Benzamides; Fibromatosis, Aggressive; Humans; Imatinib Mesylate; Longitudinal Studies; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Rotator Cuff | 2014 |
PDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cells, Cultured; Genes, p16; Humans; Imatinib Mesylate; Mice; Mice, Knockout; Muscle Neoplasms; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Rhabdomyosarcoma, Alveolar; Xenograft Model Antitumor Assays | 2008 |